Acumen Pharmaceuticals (ABOS) vs Voyager Therapeutics (VYGR)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Acumen Pharmaceuticals (ABOS) has outperformed Voyager Therapeutics (VYGR) over the past year, gaining 11.7% versus a loss of 47.8%. Over five years, VYGR leads with a -39.8% price change compared with -84.5% for ABOS. Voyager Therapeutics is the larger company by market cap ($152.2 million vs $151.9 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ABOS | VYGR |
|---|---|---|
| Share price | $2.10 | $2.47 |
| Market cap | $151.87M | $152.20M |
| 1-day change | +3.45% | +0.41% |
| YTD return | -0.47% | -37.15% |
| 1-year return | +11.70% | -47.78% |
| 5-year return | -84.50% | -39.76% |
| EPS (TTM) | $-1.56 | $-1.81 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $3.60 | $5.55 |
| 52-week low | $1.50 | $2.39 |
| Distance from 52-week high | -41.67% | -55.50% |
| Average volume | 429.73K | 568.40K |
| Shares outstanding | 72.32M | 61.62M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Biological Products (No Diagnostic Substances) |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ABOS has outperformed VYGR by 59.5 percentage points over the past year.
ABOS vs VYGR FAQ
Which is bigger, Acumen Pharmaceuticals or Voyager Therapeutics?
Voyager Therapeutics (VYGR) is larger, with a market capitalization of $152.20M compared with $151.87M for Acumen Pharmaceuticals (ABOS).
Which stock has performed better over the past year, ABOS or VYGR?
ABOS returned +11.70% over the past 12 months, compared with -47.78% for VYGR (price return, excluding dividends). Past performance does not predict future results.
Are Acumen Pharmaceuticals and Voyager Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Biological Products (No Diagnostic Substances) industry within the Health Care sector.